We serve Chemical Name:2-Methyl-N-(m-tolyl)benzamide CAS:56776-45-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Methyl-N-(m-tolyl)benzamide
CAS.NO:56776-45-5
Synonyms:2-methyl-N-(3-methylphenyl)benzamide
Molecular Formula:C15H15NO
Molecular Weight:225.28600
HS Code:2924299090
Physical and Chemical Properties:
Melting point:144ºC
Boiling point:292.9ºC at 760 mmHg
Density:1.21
Index of Refraction:1.619
PSA:29.10000
Exact Mass:225.11500
LogP:3.62870
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-methyl-N-(3-methylphenyl)benzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methyl-N-(3-methylphenyl)benzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-N-(3-methylphenyl)benzamide Use and application,2-methyl-N-(3-methylphenyl)benzamide technical grade,usp/ep/jp grade.
Related News: Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 2-Methyl-N-(m-tolyl)benzamide manufacturer Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 2-Methyl-N-(m-tolyl)benzamide supplier Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 2-Methyl-N-(m-tolyl)benzamide vendor In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 2-Methyl-N-(m-tolyl)benzamide factory The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.
